Nikhil Gandasi

Dr. Nikhil Gandasi

Indian Institute of Science Bangalore, Bengaluru, India
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 February 2018 in Cell Metabolism
Verified
Journal Article
Closed access
Nikhil GandasiNikhil Gandasi
Nikhil Gandasi
PYPeng Yin
Peng Yin
MOMuhmmad Omar-Hmeadi
Muhmmad Omar-Hmeadi
ELEmilia Ottosson Laakso
Emilia Ottosson Laakso
PVPetter Vikman
Petter Vikman
SBSebastian Barg
Sebastian Barg

20 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MOMuhmmad Omar-Hmeadi
Muhmmad Omar-Hmeadi
PLPer-Eric Lund
Per-Eric Lund
Nikhil GandasiNikhil Gandasi
Nikhil Gandasi
ATAnders Tengholm
Anders Tengholm
SBSebastian Barg
Sebastian Barg
Glucagon is released from pancreatic α-cells to activate pathways that raise blood glucose. Its secretion is regulated by α-cell-intrinsic glucose sensing and paracrine control through insulin and somatostatin. To understand the inadequately high glucagon levels that contribute to hyperglycemia in type-2 diabetes (T2D), we analyzed granule behavior, exocytosis and membrane excitability in α-cells of 68 non-diabetic and 21 T2D human donors. We report that exocytosis is moderately reduced in α-cells of T2D donors, without changes in voltage-dependent ion currents or granule trafficking. Dispersed α-cells have a non-physiological V-shaped dose response to glucose, with maximal exocytosis at hyperglycemia. Within intact islets, hyperglycemia instead inhibits α-cell exocytosis, but not in T2D or when paracrine inhibition by insulin or somatostatin is blocked. Surface expression of somatostatin-receptor-2 is reduced in T2D, suggesting a mechanism for the observed somatostatin resistance. Thus, elevated glucagon in human T2D may reflect α-cell insensitivity to paracrine inhibition at hyperglycemia.

21 January 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
VPVolodymyr Petrenko
Volodymyr Petrenko
Nikhil GandasiNikhil Gandasi
Nikhil Gandasi
DSDaniel Sage
Daniel Sage
ATAnders Tengholm
Anders Tengholm
SBSebastian Barg
Sebastian Barg
CDCharna Dibner
Charna Dibner
Circadian clocks operative in pancreatic islets participate in the regulation of insulin secretion in humans and, if compromised, in the development of type 2 diabetes (T2D) in rodents. Here we demonstrate that human islet α- and β-cells that bear attenuated clocks exhibit strongly disrupted insulin and glucagon granule docking and exocytosis. To examine whether compromised clocks play a role in the pathogenesis of T2D in humans, we quantified parameters of molecular clocks operative in human T2D islets at population, single islet, and single islet cell levels. Strikingly, our experiments reveal that islets from T2D patients contain clocks with diminished circadian amplitudes and reduced in vitro synchronization capacity compared to their nondiabetic counterparts. Moreover, our data suggest that islet clocks orchestrate temporal profiles of insulin and glucagon secretion in a physiological context. This regulation was disrupted in T2D subjects, implying a role for the islet cell-autonomous clocks in T2D progression. Finally, Nobiletin, an agonist of the core-clock proteins RORα/γ, boosted both circadian amplitude of T2D islet clocks and insulin secretion by these islets. Our study emphasizes a link between the circadian clockwork and T2D and proposes that clock modulators hold promise as putative therapeutic agents for this frequent disorder.

8 May 2017 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Nikhil GandasiNikhil Gandasi
Nikhil Gandasi
PYPeng Yin
Peng Yin
MRMichela Riz
Michela Riz
MCMargarita V. Chibalina
Margarita V. Chibalina
GCGiuliana Cortese
Giuliana Cortese
SBSebastian Barg
Sebastian Barg
Loss of first-phase insulin secretion is an early sign of developing type 2 diabetes (T2D). Ca2+ entry through voltage-gated L-type Ca2+ channels triggers exocytosis of insulin-containing granules in pancreatic β cells and is required for the postprandial spike in insulin secretion. Using high-resolution microscopy, we have identified a subset of docked insulin granules in human β cells and rat-derived clonal insulin 1 (INS1) cells for which localized Ca2+ influx triggers exocytosis with high probability and minimal latency. This immediately releasable pool (IRP) of granules, identified both structurally and functionally, was absent in β cells from human T2D donors and in INS1 cells cultured in fatty acids that mimic the diabetic state. Upon arrival at the plasma membrane, IRP granules slowly associated with 15 to 20 L-type channels. We determined that recruitment depended on a direct interaction with the synaptic protein Munc13, because expression of the II–III loop of the channel, the C2 domain of Munc13-1, or of Munc13-1 with a mutated C2 domain all disrupted L-type channel clustering at granules and ablated fast exocytosis. Thus, rapid insulin secretion requires Munc13-mediated recruitment of L-type Ca2+ channels in close proximity to insulin granules. Loss of this organization underlies disturbed insulin secretion kinetics in T2D.

1 April 2018 in EBioMedicine
Verified
Journal Article
Open access
SKSergiy V. Korol
Sergiy V. Korol
ZJZhe Jin
Zhe Jin
YJYang Jin
Yang Jin
ABAmol Bhandage
Amol Bhandage
ATAnders Tengholm
Anders Tengholm
BBB. Birnir
B. Birnir
In human pancreatic islets, the neurotransmitter γ-aminobutyric acid (GABA) is an extracellular signaling molecule synthesized by and released from the insulin-secreting β cells. The effective, physiological GABA concentration range within human islets is unknown. Here we use native GABAA receptors in human islet β cells as biological sensors and reveal that 100-1000nM GABA elicit the maximal opening frequency of the single-channels. In saturating GABA, the channels desensitized and stopped working. GABA modulated insulin exocytosis and glucose-stimulated insulin secretion. GABAA receptor currents were enhanced by the benzodiazepine diazepam, the anesthetic propofol and the incretin glucagon-like peptide-1 (GLP-1) but not affected by the hypnotic zolpidem. In type 2 diabetes (T2D) islets, single-channel analysis revealed higher GABA affinity of the receptors. The findings reveal unique GABAA receptors signaling in human islets β cells that is GABA concentration-dependent, differentially regulated by drugs, modulates insulin secretion and is altered in T2D.